Gradient Investments’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-158,610
| Closed | -$4.54M | – | 1002 |
|
|
2024
Q2 | $4.54M | Buy |
158,610
+20,183
| +15% | +$577K | 0.1% | 151 |
|
|
2024
Q1 | $4.04M | Sell |
138,427
-1,522
| -1% | -$44.5K | 0.09% | 155 |
|
|
2023
Q4 | $4.72M | Buy |
139,949
+34,723
| +33% | +$1.17M | 0.11% | 140 |
|
|
2023
Q3 | $3.23M | Buy |
105,226
+3,317
| +3% | +$102K | 0.09% | 150 |
|
|
2023
Q2 | $4.08M | Buy |
101,909
+22,160
| +28% | +$888K | 0.11% | 142 |
|
|
2023
Q1 | $3.25M | Buy |
79,749
+8,002
| +11% | +$327K | 0.09% | 148 |
|
|
2022
Q4 | $2.77M | Buy |
71,747
+14,938
| +26% | +$577K | 0.09% | 161 |
|
|
2022
Q3 | $3.02M | Sell |
56,809
-33,153
| -37% | -$1.76M | 0.09% | 152 |
|
|
2022
Q2 | $5.25M | Sell |
89,962
-31,579
| -26% | -$1.84M | 0.15% | 135 |
|
|
2022
Q1 | $9.28M | Sell |
121,541
-18,632
| -13% | -$1.42M | 0.24% | 115 |
|
|
2021
Q4 | $8.43M | Buy |
140,173
+56,725
| +68% | +$3.41M | 0.21% | 124 |
|
|
2021
Q3 | $4.67M | Buy |
83,448
+21,637
| +35% | +$1.21M | 0.13% | 143 |
|
|
2021
Q2 | $3.75M | Buy |
61,811
+6,534
| +12% | +$397K | 0.11% | 147 |
|
|
2021
Q1 | $3.87M | Buy |
+55,277
| New | +$3.87M | 0.13% | 142 |
|
|
2020
Q1 | – | Sell |
-204
| Closed | -$9K | – | 1203 |
|
|
2019
Q4 | $9K | Hold |
204
| – | – | ﹤0.01% | 731 |
|
|
2019
Q3 | $8K | Hold |
204
| – | – | ﹤0.01% | 711 |
|
|
2019
Q2 | $9K | Buy |
+204
| New | +$9K | ﹤0.01% | 679 |
|